Altre lingue

06/03 DIARY - Italy to April 30
03/03 DIARY - Italy to April 30
03/03 Italy - Factors to watch on March 3
27/02 DIARY - Italy to April 30
25/02 DIARY - Italy to April 30
19/02 Le calme avant la tempête ?
18/02 DIARY - Italy to March 31
18/02 Italy's Recordati is looking at possible M&A deals, CEO says
18/02 Multiples problèmes
18/02 Italy - Factors to watch on February 18
17/02 Italy's Recordati targets 2026 core profit increase
17/02 RECORDATI REPORTS STRONG PRELIMINARY FULL YEAR 2025 RESULTS: REVENUE +11.8%, EBITDA(1) +14.5%, ADJUSTED NET INCOME(2) +14.5%
17/02 Recordati Industria Chimica E Farmaceutica S.P.A. Provides Earnings Guidance for the Year 2026; Re-Affirms Earnings Guidance for the Year 2027
17/02 RECORDATI REPORTS STRONG PRELIMINARY FULL YEAR 2025 RESULTS: REVENUE 11.8%, EBITDA 14.5%, ADJUSTED NET INCOME 14.5%
17/02 Recordati FY EBITDA EUR 991.1 mln
17/02 Italy - Factors to watch on February 17
16/02 Galderma dévoile le nom de son nouveau directeur financier, Jefferies apprécie
16/02 Galderma Group AG Announces the Appointment of Luigi La Corte as Chief Financial Officer, Effective May 1, 2026
16/02 Dermatology Company Galderma Group Names New CFO
16/02 Galderma ernennt Luigi La Corte zum Finanzchef
13/02 Diary - Europe's STOXX 600 Corporate Earnings Week Ahead
13/02 DIARY - Italy to March 31
12/02 Avis d'analystes du jour : TotalEnergies qui rit, Dassault systèmes qui pleure
12/02 Des résultats qui ne pardonnent pas
12/02 Italy - Factors to watch on February 12
Non ci sono risultati per questa ricerca
SPRING SALE -40% : I migliori strumenti riservati agli abbonati per individuare gli investimenti di domani !
g
:
:
ENTRA ORA